EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
50 hedge funds and large institutions have $120M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+11
Holders Change %
+28.21%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
13
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EC
EcoR1 Capital
San Francisco,
California
|
$12.7M |
2 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
$8.32M |
3 |
Jennison Associates
New York
|
$15.3M |
4 |
GC
GMT Capital
Atlanta,
Georgia
|
$3.46M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.24M |